pyrindamycin a has been researched along with indoline in 1 studies
| Studies (pyrindamycin a) | Trials (pyrindamycin a) | Recent Studies (post-2010) (pyrindamycin a) | Studies (indoline) | Trials (indoline) | Recent Studies (post-2010) (indoline) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 427 | 0 | 286 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, JP; Handl, HL; Hartley, JA; Howard, TT; Hudson, SJ; Kiakos, K; Lee, M; Lingerfelt, BM; McNulty, L; Price, CA; Purnell, BL; Scott, AE; Summerville, K; Townes, HM | 1 |
1 other study(ies) available for pyrindamycin a and indoline
| Article | Year |
|---|---|
Novel furano analogues of duocarmycin C1 and C2: design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues.
Topics: Animals; Antineoplastic Agents, Alkylating; Binding Sites; Bone Marrow Cells; Cell Cycle; Cell Division; DNA; DNA Adducts; Drug Design; Drug Screening Assays, Antitumor; Duocarmycins; Furans; Hematopoietic Stem Cells; Indoles; Mice; Models, Molecular; Pyrroles; Quinolines; Structure-Activity Relationship | 2002 |